Randomised trial of oral morphine for chronic non-cancer pain

Lancet

Volumn 347, Issue 8995, 1996, Pages 143-146

  Moulin, Dwight E ^a,b   Iezzi, Anthony ^b   Amireh, Rasheed ^a   Sharpe, Wendy K J ^a   Boyd, David ^a   Merskey, Harold ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT; BENZATROPINE; MORPHINE SULFATE; NARCOTIC ANALGESIC AGENT;

ABDOMINAL PAIN; ADULT; AGED; ANALGESIA; APPETITE DISORDER; ARTICLE; CHRONIC PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONFUSION; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; DOUBLE BLIND PROCEDURE; DRY SKIN; FATIGUE; HUMAN; INSOMNIA; NARCOTIC DEPENDENCE; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SUSTAINED RELEASE PREPARATION; TREATMENT OUTCOME; VERTIGO; VISUAL IMPAIRMENT; VOMITING; XEROSTOMIA;

EID: 0030047924     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)90339-6     Document Type: Article

References (35)

1. Joranson DE, Lietman R. The McNeil National Pain Study. New York: Louis Harris and Associates, 1994.
2. Taub A. Opioid analgesics in the treatment of chronic intractable pain of non-neoplastic origin. In: Kiathata LM, Collins D, eds. Narcotic analgesics in anesthesiology. Baltimore: Williams and Wilkins, 1982: 199-208.
3. Portenoy RK, Foley KM. Chronic use of opioid analgesics in non-malignant pain: report of 38 cases. Pain 1986; 25: 171-86.
4. Boukoms AJ, Masand P, Murray GB, Cassem EH, Stern TA, Tesar GE. Chronic nonmalignant pain teated with long-term oral narcotic analgesics. Ann Clin Psychiatry 1992; 4: 185-92.
5. Tennant FS, Uclman GF. Narcotic maintenance for chronic pain: medical and legal guidelines. Postgrad Med 1983; 73: 81-94.
6. France RD, Urban BJ, Keefe FJ. Long-term use of narcotic analgesics in chronic pain. Soc Sci Med 1984; 19: 1379-82.
7. Zenz M, Strumpf M, Tryba M. Long-term oral opioid therapy in patients with chronic nonmalignant pain. J Pain Symptom Manage 1992; 7: 69-77.
8. Maruta T, Swanson DW. Problems with the use of oxycodone compound in patients with chronic pain. Pain 1981; 11: 389-96.
9. Maruta T, Swanson DW, Finlayson RE. Drug abuse and dependency in patients with chronic pain. Mayo Clin Proc 1979; 54: 241-44.
10. McNairy SL, Maruta T, Ivnik RJ, Swanson DW, Ilstrup DM. Prescription medication dependence and neuropsychologic function. Pain 1984; 18: 169-77.
11. Turner JA, Calsyn DA, Fordyce WE, Ready LB. Drug utilization pattern in chronic pain patients. Pain 1982; 12: 357-63.
12. Kolb L. Types and characteristics of drug addicts. Men Hyg 1925; 9: 300-13.
13. Rayport M. Experience in the management of patients medically addicted to narcotics. JAMA 1954; 156: 684-91.
14. Porter J, Jick H. Addiction rare in patients treated with narcotics. N Engl J Med 1980; 302: 123.
15. Perry S, Heidrich G. Management of pain during debridement: a survey of U. S. burn units. Pain 1982; 13: 267-80.
16. Medina JL, Diamond S. Drug dependency in patients with chronic headache. Headache 1977; 17: 12-14.
17. Watson CPN. Antidepressant drugs as adjuvant analgesics. J Pain Symptom Manage 1994; 9: 392-405.
18. Turk DC, Meichenbaum D. A cognitive-behavioural approach to pain management. In: Wall PD, Melzack R, eds. Textbook of pain. 3rd ed. Edinburgh: Churchill Livingstone, 1994: 1337-48.
19. Derogatis LR. The SCL-90-R. Baltimore: Clinical Psychometrics Research, 1975.
20. McNair DM, Lorr M. Manual. Profile of mood states. San Diego: Educational and Industrial Testing Service, 1982.
21. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981; 19: 787-805.
22. Tait RC, Pollard CA, Margolis RB, Duckro PN, Kruse SJ. The Pain Disability Index: psychometric and validity data. Arch Phys Med Rehab 1987; 68: 438-41.
23. Faust D, Fogel BS. The development and initial validation of a sensitive cognitive screening test. J Nerv Ment Dis 1989; 177: 25-31.
24. Von Korff M. Epidemiological and survey methods: chronic pain assessment. In: Turk DC, Melzack R, eds. Handboook of pain assessment. New York: Guildford Press, 1992: 391-408.
25. Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain 1975; 1: 277-99.
26. Jasinski DR. Assessmentof the abuse potentiality of morphine-like drugs (methods used in man). In: Martin WR, ed. Drug addiction I: morphine, sedative/hypnotic and alcohol dependence. Handb Exp Pharmacol 1977; 45: 197-258.
27. Max MB, Schafer SC, Culnane M, Dubner R, Gracely RH. Association of pain relief with drug side effects in post-herpetic neuralgia: a single-dose study of clonidine, codeine, ibuprofen and placebo. Clin Pharm Ther 1988; 43: 363-71.
28. Jones B, Kenwood MG. Design and analysis of crossover trials. New York: Chapman and Hall, 1989.
29. Reidenberg MM, Portenoy RK. Commentary: the need for an open mind about the treatment of chronic nonmalignant pain. Clin Pharmacol Ther 1994; 55: 367-69.
30. Cherny NI, Portenoy RK. Practical issues in the management of cancer pain. In: Wall PD, Melzack R, eds. Textbook of pain. 3rd ed. Edinburgh: Churchill Livingstone, 1994: 1437-67.
31. Flor H, Fydrich T, Turk DC. Efficacy of multidisciplinary pain treatment centers: a meta-analytic review. Pain 1992; 49: 221-30.
32. Ward SE, Gordon D. Application of the American Pain Society quality assurance standards. Pain 1994; 56: 299-306.
33. Jadad AR, Carroll D, Glynn CJ, Moore RA, McQuay HJ. Morphine responsiveness of chronic pain: double-blind randomised crossover study with patient-controlled analgesia. Lancet 1992; 339: 1367-71.
34. Kupers RC, Konings H, Adriaensen H, Gybels JM. Morpine differentially affects the sensory and affective pain ratings in neurogenic and idiopathic forms of pain. Pain 1991; 47: 5-12.
35. Botney N, Fields HL. Amitriptyline potentiates morphine analgesia by a direct action on the central nervous system. Ann Neurol 1983; 13: 160-64.